NT3 Gene

📖 Wiki Page

gene1193 wordssynced 2026-04-02

NT3 Gene

Introduction

Nt3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@maisonpierre1990]
title: NT3 Gene [@tessarollo1994]

--- [@lamballe1994]

<div class="infobox .infobox-gene"> [@lyons1999]
<table> [@murer2001]
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">NTF3 (Neurotrophin 3)</th></tr> [@zhang2009]
<tr><td><b>Full Name</b></td><td>Neurotrophin 3</td></tr> [@nagahara2009]
<tr><td><b>Chromosomal Location</b></td><td>12p13.31</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[4900](https://www.ncbi.nlm.nih.gov/gene/4900)</td></tr>
<tr><td><b>OMIM</b></td><td>[162660](https://www.omim.org/entry/162660)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000185652](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185652)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P20783](https://www.uniprot.org/uniprot/P20783)</td></tr>
<tr><td><b>Protein Class</b></td><td>Neurotrophic factor</td></tr>
<tr><td><b>Primary Receptor</b></td><td>TrkC (TyrKc)</td></tr>
<tr><td><b>Gene Family</b></td><td>Neurotrophin</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">23 edges</a></td>
</tr>
</table>
</div>

...

NT3 Gene

Introduction

Nt3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@maisonpierre1990]
title: NT3 Gene [@tessarollo1994]

--- [@lamballe1994]

Overview

Mermaid diagram (expand to render)

Neurotrophin-3 (NT-3), encoded by the NTF3 gene, is a member of the neurotrophin family of growth factors that also includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-4 (NT-4). NT-3 promotes the survival, differentiation, and functional maintenance of neuronal populations during development and throughout life. Unlike other neurotrophins, NT-3 has a broader receptor repertoire, binding with highest affinity to TrkC but also activating TrkB and TrkA with lower affinity.

Molecular Mechanisms

Receptor Binding and Signaling

NT-3 binds to the TrkC receptor (tropomyosin receptor kinase C), a receptor tyrosine kinase, with high affinity (Kd ~10⁻¹¹ M). Binding induces receptor dimerization and autophosphorylation, activating three major downstream signaling cascades:

PI3K/Akt Pathway: Phosphatidylinositol 3-kinase (PI3K) activation leads to Akt phosphorylation, promoting neuronal survival through phosphorylation of BAD and activation of [mTOR](/entities/mtor) signaling.

MAPK/ERK Pathway: Ras/Raf/MEK/ERK cascade activation promotes neuronal differentiation, dendritic growth, and synaptic plasticity through transcription factor activation (CREB, Elk-1).

PLCγ Pathway: Phospholipase C-gamma (PLCγ) activation increases intracellular Ca²⁺ and activates PKC, modulating synaptic transmission and plasticity.

Precursor Processing

NT-3 is synthesized as a pre-proprotein (pre-pro-NT3), with the preprodomain directing secretion via the secretory pathway. The mature NT-3 protein (119 amino acids) forms a homodimer that is secreted and can bind to both p75NTR (pan-neurotrophin receptor) and Trk receptors. The p75NTR binding can either enhance or inhibit Trk signaling depending on cellular context.

Normal Function

Nervous System Development

During embryonic development, NT-3 is critical for:

Proprioceptive sensory neuron development and survival
Sympathetic neuron differentiation
Cholinergic neuron development in the basal forebrain
GABAergic neuron maturation in the [cortex](/brain-regions/cortex)
Axonal guidance via chemotropic effects

Adult Nervous System

In the adult brain, NT-3 maintains:

Synaptic plasticity in the hippocampus and cortex
Neuronal survival in the basal forebrain cholinergic system
Sensory neuron function in peripheral nervous system
Cognitive function particularly in memory and learning

Disease Associations

Alzheimer's Disease

NT-3 levels are reduced in AD brains, particularly in the hippocampus and cortex. NT-3 deficiency correlates with cholinergic neuron loss and memory deficits. Therapeutic strategies aim to enhance NT-3 signaling to protect cholinergic [neurons](/entities/neurons) and improve synaptic function.

Parkinson's Disease

NT-3 provides neuroprotection to dopaminergic neurons in the substantia nigra. Studies show NT-3 can protect against MPTP-induced parkinsonism in animal models. Reduced NT-3 expression may contribute to dopaminergic neuron vulnerability.

Huntington's Disease

NT-3 signaling is impaired in HD, with reduced TrkC expression in the striatum. NT-3 delivery studies show protection of striatal neurons and improvement in behavioral deficits in mouse models.

Peripheral Neuropathy

NT-3 promotes peripheral nerve regeneration and sensory neuron survival. NT-3 gene therapy has shown promise in diabetic neuropathy and chemotherapy-induced peripheral neuropathy models.

Spinal Cord Injury

NT-3 promotes axonal regeneration and functional recovery after spinal cord injury. Combinatorial approaches with NT-3 and other neurotrophins show enhanced regeneration.

Expression Pattern

Central Nervous System

NT-3 is widely expressed in the developing and adult CNS:

[Hippocampus](/brain-regions/hippocampus): Highest expression in dentate gyrus and CA3 region
Cerebral cortex: Layer-specific expression in pyramidal neurons
Basal forebrain: Cholinergic neuron targets
Cerebellum: Purkinje cells and granule cells
Spinal cord: Motor neurons and interneurons

Peripheral Nervous System

Skeletal muscle (muscle spindles)
Cardiac tissue
Skin (dermal fibroblasts)
Gastrointestinal tract

Therapeutic Implications

Gene Therapy Approaches

AAV-mediated NT-3 delivery to the brain or spinal cord has shown efficacy in animal models of AD, PD, and spinal cord injury. Clinical trials for peripheral neuropathy are underway.

Small Molecule Mimetics

Drug discovery efforts focus on developing small molecules that activate TrkC or enhance NT-3 signaling. These include TrkC agonists and BDNF/TrkC heterodimer mimetics.

Protein Delivery

Recombinant NT-3 protein delivery via intranasal or intravenous administration is being explored for CNS delivery. Challenges include short half-life and blood-brain barrier penetration.

Cell-Based Therapy

NTF3 gene-modified cells (mesenchymal stem cells, neural progenitor cells) provide sustained NT-3 release in target regions.

Animal Models

NTF3 Knockout Mice

NTF3⁻/⁻ mice die perinatally with severe sensory and autonomic deficits. Survivors show loss of proprioceptive neurons, hippocampal abnormalities, and motor coordination deficits.

Transgenic Overexpression

NT-3 transgenic mice show enhanced synaptic plasticity, improved memory, and increased hippocampal neuron survival. Used to study NT-3 therapeutic potential.

Viral Vector Models

AAV-NT3 and lentiviral-NT3 delivery in mouse models of AD, PD, and spinal cord injury demonstrates neuroprotection and functional improvement.

Research Directions

[Blood-brain barrier](/entities/blood-brain-barrier) penetration strategies for NT-3 delivery
TrkC-selective agonists to minimize off-target effects
Combination therapies with other neurotrophic factors (BDNF, GDNF)
Biomarker development for NT-3 therapeutic monitoring
Clinical trials for peripheral neuropathy and spinal cord injury

Background

The study of Nt3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

Allen Brain Atlas Links

The Allen Brain Atlas provides comprehensive gene expression data across brain regions and cell types.

[Allen Human Brain Atlas](https://human.brain-map.org/) — Gene expression data across the adult human brain
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — Gene expression in mouse brain
[Allen Cell Type Atlas](https://celltype.brain-map.org/) — Single-cell transcriptomics data
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) — Developmental expression data
[Allen Brain Map Portal](https://portal.brain-map.org/) — Access to all Allen Institute brain data

Gene-Specific Expression Data

Search for expression data on the Allen Brain Atlas:

[Human Brain Atlas search for this gene](https://human.brain-map.org/microarray/search/show?search_term=NT3)

External Links

[NCBI Gene - NTF3](https://www.ncbi.nlm.nih.gov/gene/4900)
[UniProt - NTF3](https://www.uniprot.org/uniprot/P20783)
[Ensembl - NTF3](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185652)
[GeneCards - NTF3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTF3)

References

[Ernfors P, et al. (1994), Neurotrophin-3 is required for proper development of skin sensory neurons (1994)](https://pubmed.ncbi.nlm.nih.gov/7909099/)

[Maisonpierre PC, et al. (1990), NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression (1990)](https://pubmed.ncbi.nlm.nih.gov/2155254/)

[Tessarollo L, et al. (1994), NT-3, a neurotrophic factor for peripheral sensory and sympathetic neurons (1994)](https://pubmed.ncbi.nlm.nih.gov/7530388/)

[Lamballe F, et al. (1994), Diversity of Trk neurotrophin receptor functions (1994)](https://pubmed.ncbi.nlm.nih.gov/7531628/)

[Lyons WE, et al. (1999), Administration of NT-3 into the central nervous system of adult rats prevents axotomy-induced death of facial motor neurons (1999)](https://pubmed.ncbi.nlm.nih.gov/10398052/)

[Murer MG, et al. (2001), Chronic elevation of NT-3 by adenoviral gene transfer induces axonal sprouting and modifies motor function (2001)](https://pubmed.ncbi.nlm.nih.gov/11483252/)

[Zhang Y, et al. (2009), AAV-NT3 gene therapy enhances cognitive function in a rat model of Alzheimer's disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19219566/)

[Nagahara AH, et al. (2009), Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Parkinson's disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19198614/)

Pathway Diagram

The following diagram shows the key molecular relationships involving NT3 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

NT3 Gene

NT3 Gene

Introduction

NT3 Gene

Introduction

Overview

Molecular Mechanisms

Receptor Binding and Signaling

Precursor Processing

Normal Function

Nervous System Development

Adult Nervous System

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Peripheral Neuropathy

Spinal Cord Injury

Expression Pattern

Central Nervous System

Peripheral Nervous System

Therapeutic Implications

Gene Therapy Approaches

Small Molecule Mimetics

Protein Delivery

Cell-Based Therapy

Animal Models

NTF3 Knockout Mice

Transgenic Overexpression

Viral Vector Models

Research Directions

Background

Brain Atlas Resources

Allen Brain Atlas Links

Gene-Specific Expression Data

See Also

External Links

References

Pathway Diagram